title: Comparison of intraperitoneal antithrombin III and heparin in experimental peritonitis.
abstract: The antifibrotic effect of heparin, an anticoagulant used routinely in the treatment of peritonitis, is unknown, whereas antithrombin III (AT-III) has both anticoagulant and anti-inflammatory actions. The aim of this study was to compare the antifibrotic and anti-inflammatory effects of AT-III and heparin in rats with experimentally developed peritonitis while on peritoneal dialysis (PD). Sixty-four Wistar albino rats (in four groups of 16) were used in the study. Group 1 received PD solution only, group 2 had experimentally developed peritonitis in addition to PD solution; group 3 received heparin intraperitoneally for 3 days, in addition to group 2; and group 4 received AT-III intraperitoneally for 3 days, in addition to group 2. Plasma and dialysate levels of tissue-plasminogen activator were similar in heparin and AT-III groups on both day 3 and day 14. The inflammation scores of heparin and AT-III groups were also similar in both early and late phases. The fibrosis score of the AT-III group was low compared with both peritonitis and heparin groups in the early phase (p = 0.03), though it was similar in the late phase. The effects of AT-III are comparable with that of heparin in PD peritonitis in rats with experimentally developed peritonitis while on PD.
authors.affiliation: Pediatric Nephrology, Akdeniz University, Antalya, Turkey. semaakman2002@yahoo.com
authors.forename: Sema
authors.initials: S
authors.lastname: Akman
authors.forename: Mustafa
authors.initials: M
authors.lastname: Koyun
authors.forename: Tekinalp
authors.initials: T
authors.lastname: Gelen
authors.forename: Mesut
authors.initials: M
authors.lastname: Coskun
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D000990:Antithrombin III / Q000494:pharmacology*; D004195:Disease Models, Animal; D005343:Fibrinolytic Agents / Q000494:pharmacology; D005355:Fibrosis; D006493:Heparin / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D000990:Antithrombin III; D006493:Heparin